Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

VASSALLO GT Crossing14

K-Number: K232574 · 2023-10-11

Decision Date2023-10-11
Product CodeDQX
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

VASSALLO GT Crossing14 is a medical device manufactured by Filmec Co. , Ltd.. It received FDA 510(k) clearance on 2023-10-11 under approval number K232574. The device is classified under product code DQX. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the VASSALLO GT Crossing14?

VASSALLO GT Crossing14 is a medical device that received FDA 510(k) clearance on 2023-10-11. It is manufactured by Filmec Co. , Ltd.. The 510(k) number is K232574.

When was VASSALLO GT Crossing14 approved by the FDA?

VASSALLO GT Crossing14 received FDA 510(k) clearance on 2023-10-11, under approval number K232574.

What company makes VASSALLO GT Crossing14?

VASSALLO GT Crossing14 is manufactured by Filmec Co. , Ltd..

What is the FDA product code for VASSALLO GT Crossing14?

The FDA product code for VASSALLO GT Crossing14 is DQX.

Other Devices by Filmec Co. , Ltd.

Related Devices (Code: DQX)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.